Teva Pharmaceutical Industries Lt.../ US8816242098 /
11/8/2024 10:10:00 PM | Chg. -0.39 | Volume | Bid11:05:30 AM | Ask11:05:30 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
17.11USD | -2.23% | 6.23 mill. Turnover: 93.81 mill. |
17.47Bid Size: 4,000 | 17.51Ask Size: 500 | -USD | - | - |
Assets
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 6,544 | 8,073 | 7,673 | 6,868 | 6,436 | ||||||
Intangible Assets | 7,675 | 21,487 | 17,640 | 14,005 | 11,232 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | 3,966 | 4,954 | 4,924 | 4,731 | 4,422 | ||||||
Accounts Receivable | 5,350 | 7,523 | 7,128 | 5,822 | 5,676 | ||||||
Cash and Cash Equivalents | 6,946 | 988 | 963 | 1,782 | 1,975 | ||||||
Current Assets | 18,398 | 16,961 | 15,382 | 13,794 | 13,464 | ||||||
Total Assets | 54,258 | 92,890 | 70,615 | 60,683 | 57,470 |
Liabilities
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 3,594 | 2,157 | 2,069 | 1,853 | 1,718 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | 1,585 | 3,276 | 3,646 | 2,216 | 2,345 | ||||||
Provisions | 1,748 | 5,215 | 3,277 | 2,140 | 1,096 | ||||||
Liabilities | 24,331 | 57,897 | 51,870 | 44,889 | 42,407 | ||||||
Share Capital | 52 | 54 | 54 | 56 | 56 | ||||||
Total Equity | 29,769 | 33,337 | 17,359 | 14,707 | 13,972 | ||||||
Minority Interests | 158 | 1,656 | 1,386 | 1,087 | 1,091 | ||||||
Total liabilities equity | 54,258 | 92,890 | 70,615 | 60,683 | 57,470 |
Income Statement
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 19,652 | 21,903 | 22,385 | 18,854 | 16,887 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 3,352 | 2,154 | -17,484 | -1,637 | -443 | ||||||
Interest Income | -1,000 | -1,330 | -895 | -959 | -822 | ||||||
Income Before Taxes | 2,352 | 824 | -18,379 | -2,596 | -1,265 | ||||||
Income Taxes | 634 | 521 | -1,933 | -195 | -278 | ||||||
Minority Interests Profit | -9 | 18 | 184 | 322 | 1 | ||||||
Net Income | 1,588 | 329 | -16,265 | -2,150 | -999 |
Per Share
Cash Flow
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 5,542 | 5,225 | 3,507 | 2,446 | 748 | ||||||
Cash Flow from Investing Activities | -5,565 | -35,740 | 2,164 | 1,866 | 1,355 | ||||||
Cash Flow from Financing | 4,805 | 25,217 | -5,750 | -3,351 | -1,926 | ||||||
Decrease / Increase in Cash | 4,720 | -5,958 | -25 | 819 | 193 | ||||||
Employees | 32,866 | 56,960 | 51,800 | 42,535 | 40,039 |